Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

3,010 public trials 644 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC)

NCT00267748

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Pfizer Investigational Site Hot Springs, Arkansas, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Anaheim, California, United States
  • Pfizer Investigational Site Baldwin Park, California, United States
View all 156 locations
View Trial Details
Completed

Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma

NCT00444314

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Johns Hopkins University School of Medicine Baltimore, Maryland, United States
  • University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States
View Trial Details

Related conditions